Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2022-10-17 Director's Dealing
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo - Internal Dealing - Alessandro Maiello
Director's Dealing Classification · 100% confidence The document is titled 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate' (Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). The subject line explicitly mentions 'Internal Dealing'. This structure and content directly correspond to the reporting requirements for insider transactions by directors and executives. This matches the definition for Director's Dealing (Code: DIRS). The document is a formal notification template, not a general regulatory filing (RNS) or a report itself.
2022-10-17 Italian
FARMACOSMO: RICAVI DEI PRIMI NOVE MESI PARI A 46,5 MLN (+13% YoY) CRESCITA DEL PORTALE FARMACOSMO.IT (+35% YoY)
Earnings Release Classification · 99% confidence The document is titled 'Informazione Regolamentata' (Regulated Information) and is dated October 17, 2022. The subject ('Oggetto') clearly states 'RICAVI DEI PRIMI NOVE MESI PARI A 46,5 MLN (+13% YoY)' (Revenues for the first nine months equal to 46.5 million). The text details key performance indicators (KPIs) and revenue figures for the first nine months of the year, ending September 30, 2022. This content structure—reporting on a period shorter than a full year (nine months) with detailed financial and operational metrics—is characteristic of an Interim/Quarterly Report (IR). Although it is presented as a press release/communication, the core content is the comprehensive financial update for the interim period, making 'IR' the most appropriate classification over a simple 'ER' (Earnings Release, which is usually just highlights) or 'RPA' (Report Publication Announcement, as this contains the actual data, not just an announcement that data is available). 9M 2022
2022-10-17 Italian
Farmacosmo - Fabio de Concilio - Internal Dealing
Director's Dealing Classification · 99% confidence The document is a formal notification published on Euronext Growth Milan, dated October 13, 2022. The 'Oggetto' (Subject) is 'Dealing'. The template used is titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' Section 1 details the person involved (Fabio de Concilio) and their position (Amministratore Delegato - CEO/Managing Director). Section 3 identifies the issuer as FARMACOSMO. This structure precisely matches the requirements for reporting insider transactions by directors or management, which corresponds to the 'Director's Dealing' category.
2022-10-13 Portuguese
Farmacosmo: Dimissioni del Presidente del Consiglio di Amministrazione
Board/Management Information Classification · 98% confidence The document is an official communication titled "Dimissioni del Presidente del Consiglio di Amministrazione" (Resignation of the Chairman of the Board of Directors). It explicitly announces a change in senior management/board composition (the resignation of the Chairman and the assumption of the role by the CEO). This directly corresponds to the definition of Board/Management Information (MANG). Although it is a press release, the core subject matter is management change, making MANG more specific than the general Regulatory Filing (RNS). The document length (5810 chars) is substantial enough to be the primary announcement, not just a pointer to a report.
2022-10-11 Italian
Farmacosmo - Fabio de Concilio - Internal Dealing
Director's Dealing Classification · 100% confidence The document is an official notification filed on October 5, 2022, identified by 'Informazione Regolamentata n. 20253-43-2022'. The 'Oggetto' (Subject) is 'Dealing'. The template used is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This content directly corresponds to reporting insider transactions by directors or management, which maps precisely to the Director's Dealing category.
2022-10-05 Italian
Farmacosmo:Closing Per L’Acquisizione Del Capitale Sociale Di Vin.Ci. S.R.L. Ad Esito Dell’operazione Farmacosmo Detiene Circa Il 97% Di ProfumeriaWeb
M&A Activity Classification · 98% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and announces the 'CLOSING PER L'ACQUISIZIONE DEL CAPITALE SOCIALE DI VIN.CI. S.R.L.' (Closing for the acquisition of the share capital of Vin.Ci. S.r.l.). It details a significant corporate transaction (M&A activity) and provides key financial highlights of the acquired entity (ProfumeriaWeb). The metadata indicates it was received as 'Informazione Regolamentata' (Regulated Information) with the object clearly describing the transaction. While it discusses a transaction, the core nature is an announcement of a completed corporate action, which often falls under general regulatory announcements or M&A specific categories. Given the explicit focus on the completion of an acquisition/takeover, the most specific category is M&A Activity (TAR). It is not a full 10-K, an Earnings Release (ER) which focuses on periodic results, or a simple Report Publication Announcement (RPA) as it contains substantive details about the transaction itself, not just a notice that a report is available.
2022-09-29 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.